Journal
BIOPHYSICAL JOURNAL
Volume 115, Issue 11, Pages 2206-2217Publisher
CELL PRESS
DOI: 10.1016/j.bpj.2018.10.018
Keywords
-
Categories
Funding
- PhRMA Foundation Predoctoral Fellowship
- National Institutes of Health [RO1HL111649, R01EB016407]
- [F31 HL134209-02]
Ask authors/readers for more resources
iPSC-derived cardiomyocytes (iPSC-CMs) are a potentially advantageous platform for drug screening because they provide a renewable source of human cardiomyocytes. One obstacle to their implementation is their immature electrophysiology, which reduces relevance to adult arrhythmogenesis. To address this, dynamic clamp is used to inject current representing the insufficient potassium current, I-K1, thereby producing more adult-like electrophysiology. However, dynamic clamp requires patch clamp and is therefore low throughput and ill-suited for large-scale drug screening. Here, we use optogenetics to generate such a dynamic-clamp current. The optical dynamic clamp (ODC) uses outward-current-generating opsin, ArchT, to mimic I-K1, resulting in more adult-like action potential morphology, similar to I-K1 injection via classic dynamic clamp. Furthermore, in the presence of an I-Kr, blocker, ODC revealed expected action potential prolongation and reduced spontaneous excitation. The ODC presented here still requires an electrode to measure V-m but provides a first step toward contactless dynamic clamp, which will not only enable high-throughput screening but may also allow control within multicellular iPSC-CM formats to better recapitulate adult in vivo physiology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available